These results suggest that the blockade of CCR2 may attenuate inflammatory macrophage and neutrophil accumulation and liver fibrosis by inactivating the JAK-STAT, TNF-NFκB, and MAPK-ERK signaling pathways. Here, NFKB1 is linked to Hepatic fibrosis.